The forecast for the sold production of medicaments containing alkaloids or derivatives thereof (excluding hormones or antibiotics) in Germany indicates a steady upward trend from 2024 to 2028. Starting at 16.698 billion Euros in 2024, production is expected to grow to 17.579 billion Euros in 2028. This represents an average annual growth rate (CAGR) over these five years.
Year-on-year growth is consistent, showing increases from 2024 through 2028, with each year seeing a rise in value. The collected data indicates a strong and stable growth trajectory for the sector.
- Future trends to watch for: Increased investment in research and development within the pharmaceutical sector may lead to substantial innovations in medicaments. Additionally, regulatory changes and shifts in consumer health trends could impact demand for alkaloid-derived pharmaceuticals.
